« Previous
Next »
American Journal of Cardiology
Volume 104, Issue 2
, Pages 158-163
, 15 July 2009
Sudden Cardiac Death in Patients With Silent Myocardial Ischemia After Myocardial Infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II])
References
- . Silent cardiac ischemia. Curr Opin Cardiol. 2002;17:537–542
- . Silent myocardial ischemia: recent developments. Curr Atheroscler Rep. 2005;7:155–163
- . Silent myocardial ischemia. Circulation. 2003;108:1263–1277
- . Initial clinical presentation of cardiac disease in asymptomatic men with silent myocardial ischemia and angiographically documented coronary artery disease (the Oslo Ischemia Study). Am J Cardiol. 1993;72:629–633
- . Effects of anti-ischemic drug therapy in silent myocardial ischemia type I—the Swiss Interventional Study on Silent Ischemia Type I (SWISSI I): a randomized, controlled pilot study. Eur Heart J. 2007;28:2110–2117
- . Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007;297:1985–1991
- . Sudden death and silent myocardial ischemia. Am Heart J. 1989;117:177–184
- . Prognostic significance of myocardial ischemia by dobutamine stress echocardiography in patients without angina pectoris after coronary revascularization. Am J Cardiol. 2008;102:1156–1158
- . Prevalence of and association between silent myocardial ischemia and new coronary events in older men and women with and without cardiovascular disease. J Am Geriatr Soc. 2002;50:1075–1078
- . Three-year follow-up of patients with silent ischemia in the subacute phase of myocardial infarction after thrombolysis and early coronary intervention. Int J Cardiol. 1999;71:167–178
- . Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. N Engl J Med. 1992;326:1451–1455
- . Clinical classification of cardiac deaths. Circulation. 1982;65:457–464
- . Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med. 1993;119:1187–1197
- . American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Heart Rhythm. 2008;5:e1–e21
- . Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001;22:1374–1450
- . Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–1940
- . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
- . The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250–258
- . Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol. 2006;97:480–484
- . The impact of very late revascularization of occluded infarct-related artery on cardiac mortality and the incidence of sudden death in survivors of acute myocardial infarction—long-term observation. Med Sci Monit. 2002;8:364–370
- . Prediction of arrhythmic events after myocardial infarction based on signal-averaged electrocardiogram and ejection fraction. Pacing Clin Electrophysiol. 2008;31:221–228
- . Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2008;51:956–964
- . Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J. 2005;26:2039–2045
- . Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol. 2007;50:1150–1157
- . Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–2407
The Swiss Interventional Study on Silent Ischemia Type II was funded by a grant from the von Muralt Stiftung/Swiss Heart Foundation, Berne, Switzerland, and supported by unrestricted grants from Hoechst Pharma, Merck Pharma, and Pfizer, all in Switzerland. Andreas Schoenenberger, MD, was supported by a Forschungskolleg Geriatrie Grant from the Robert Bosch Foundation, Stuttgart, Germany. None of the granting institutions had any influence on the study design, data collection, analysis and interpretation. All authors have disclosed all associations (either commercial or industrial) that might pose a conflict of interest.
PII: S0002-9149(09)00723-1
doi: 10.1016/j.amjcard.2009.03.019
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 104, Issue 2
, Pages 158-163
, 15 July 2009
